Literature DB >> 26170498

Antimicrobial resistance: a priority for global health action.

Arthur Chioro1, Awa Marie Coll-Seck2, Bent Høie3, Nila Moeloek4, Aaron Motsoaledi5, Rajata Rajatanavin6, Marisol Touraine7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26170498      PMCID: PMC4490824          DOI: 10.2471/BLT.15.158998

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
From the earliest days of antibiotics, scientists have warned that without careful management of the way these powerful drugs are used, pathogens could quickly develop defences against them. Today, antimicrobial resistance is spreading faster than ever, threatening the effectiveness of many of our most important weapons against infections. Convened by the Foreign Policy and Global Health Initiative group of nations, experts met in Oslo, Norway in November 2014 to consider ways to reverse the dangerous spread of resistance to antibiotics and other antimicrobial medicines. As ministers charged with safeguarding the health of the public, we view this as a top priority. In an increasingly interconnected world, the challenge of combating antimicrobial resistance cannot be addressed by individual countries acting alone. We have therefore actively supported efforts by the World Health Organization (WHO) to develop a global action plan to combat antimicrobial resistance. While antimicrobial medicines also play an important role in agriculture, their essential function is to protect human health. Our focus is on ways to improve the stewardship of these critical medicines so they will maintain their usefulness. We recognize the burden faced by those living in poverty in low- and middle-income countries, who have limited access to these medicines, often at prices they cannot afford, forcing them to skimp on treatment courses. This puts them at particular risk from infections. Accordingly, we must simultaneously address issues of access along with improved stewardship and strengthened policies for the rational use of antimicrobial medicines. The Oslo meeting recommended that: everyone should have access to appropriate, effective and affordable antimicrobial medicines in a timely manner; the use of antimicrobials needs to be well regulated and based on medical need and appropriate diagnosis; inappropriate, unnecessary and dangerous use of these medicines must be actively discouraged; manufacturers and marketers of these medicines should become active partners in furthering appropriate use and stopping excessive and inappropriate use; the direct marketing to consumers of antimicrobial medicines by manufacturers, importers and distributors should be forbidden or tightly controlled. We are committed to combating the scourge of low-quality antimicrobial products, which risks poor health outcomes for their users as well as the spread of antimicrobial resistance. WHO has a role as the platform for discussions on this problem in the interest of public health, in particular through the SSFFC (substandard/spurious/falsely-labelled/falsified/counterfeit medical products) Member State mechanism. We will work to strengthen our health systems to accelerate the implementation of proven infection prevention and control measures that will reduce the need for antimicrobials. We will also work with other sectors – particularly agriculture, animal husbandry and manufacturing – to ensure that their use of antimicrobial agents is controlled and monitored, to end inappropriate use, prevent the contamination of food and the environment and limit the development of resistance. Certain new classes of antimicrobials, once they are developed, should be restricted to human use only and under tightly controlled conditions. Countries with limited resources and vulnerable health systems need particular help from the international community to strengthen infection prevention and control, as well as the stewardship of antimicrobial medicines. Development of sustained investments in health systems must be a common commitment. Through WHO and others, we will work together with countries that need assistance to strengthen their own capacities and systems – in particular, to meet the requirements of the International Health Regulations. Antimicrobial medicines are among humankind’s greatest scientific discoveries. They make us all safer. It is our responsibility and our pledge to rationally manage and preserve this vital resource for generations to come.
  2 in total

1.  Oslo Ministerial Declaration--global health: a pressing foreign policy issue of our time.

Authors: 
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

2.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

  2 in total
  11 in total

1.  Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.

Authors:  Xiqi Li; Cesar A Arias; Samuel L Aitken; Jessica Galloway Peña; Diana Panesso; Michael Chang; Lorena Diaz; Rafael Rios; Yazan Numan; Sammi Ghaoui; Sruti DebRoy; Micah M Bhatti; Dawn E Simmons; Isaam Raad; Ray Hachem; Stephanie A Folan; Pranoti Sahasarabhojane; Awdhesh Kalia; Samuel A Shelburne
Journal:  Clin Infect Dis       Date:  2018-07-18       Impact factor: 9.079

2.  Patient perception about the need for antibiotics after tooth extractions: A cross-sectional study.

Authors:  Berta Pérez-Amate; Rui Figueiredo; Sergio Cortés-Peral; Alba Sánchez-Torres; Eduard Valmaseda-Castellón
Journal:  J Clin Exp Dent       Date:  2021-05-01

3.  VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning.

Authors:  Jiwoong Kim; David E Greenberg; Reed Pifer; Shuang Jiang; Guanghua Xiao; Samuel A Shelburne; Andrew Koh; Yang Xie; Xiaowei Zhan
Journal:  PLoS Comput Biol       Date:  2020-01-13       Impact factor: 4.475

Review 4.  Microbiologically-Synthesized Nanoparticles and Their Role in Silencing the Biofilm Signaling Cascade.

Authors:  Dibyajit Lahiri; Moupriya Nag; Hassan I Sheikh; Tanmay Sarkar; Hisham Atan Edinur; Siddhartha Pati; Rina Rani Ray
Journal:  Front Microbiol       Date:  2021-02-25       Impact factor: 5.640

5.  Early prediction models for extended-spectrum β-lactamase-producing Escherichia coli infection in emergency department: A protocol for systematic review and meta analysis.

Authors:  Yiwu Zhou; Shu Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

6.  Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.

Authors:  Wantana Paveenkittiporn; Meghan Lyman; Caitlin Biedron; Nora Chea; Charatdao Bunthi; Amy Kolwaite; Noppavan Janejai
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-05       Impact factor: 4.887

7.  Prescription for antibiotics at drug shops and strategies to improve quality of care and patient safety: a cross-sectional survey in the private sector in Uganda.

Authors:  Anthony K Mbonye; Esther Buregyeya; Elizeus Rutebemberwa; Siân E Clarke; Sham Lal; Kristian S Hansen; Pascal Magnussen; Philip LaRussa
Journal:  BMJ Open       Date:  2016-03-15       Impact factor: 2.692

8.  Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance.

Authors:  Susan Rogers Van Katwyk; Marie Évelyne Danik; Ioana Pantis; Rachel Smith; John-Arne Røttingen; Steven J Hoffman
Journal:  Glob Health Res Policy       Date:  2016-12-13

Review 9.  Quorum-Sensing Regulation of Antimicrobial Resistance in Bacteria.

Authors:  Xihong Zhao; Zixuan Yu; Tian Ding
Journal:  Microorganisms       Date:  2020-03-17

10.  Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation.

Authors:  Melinda A Engevik; Heather A Danhof; Ritu Shrestha; Alexandra L Chang-Graham; Joseph M Hyser; Anthony M Haag; Mahmoud A Mohammad; Robert A Britton; James Versalovic; Joseph A Sorg; Jennifer K Spinler
Journal:  Gut Microbes       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.